论文部分内容阅读
2015年9月20日,中华预防医学会在杭州组织召开了流脑监测与免疫预防专家研讨会。会议报告了全球和我国流脑的防控进展,梳理了我国现行流脑疫苗(MenV)应用现状,解读了世界卫生组织(WHO)接种MenV的立场文件,系统分析了我国流脑免疫预防存在的问题。会议认为,目前从疫苗种类、接种管理等方面,我国流脑免疫预防面临较为复杂的情况和问题。新流行菌群的不断出现,需要扩大MenV的血清群覆盖范围;MenV种类多,但不同企业的接种推荐程序各异,使接种人员存在困惑;二类疫苗与一类疫苗并存,在接种管理上难度加大;流脑病例监测报告的敏感性低。会议建议对目前我国MenV的免疫策略进行适时调整;全国统一制定MenV使用指导意见,规范预防接种、信息登记和接种率统计;提高流脑监测和病例报告的敏感性;积极开展MenV的应用性研究。
On September 20, 2015, the Chinese Preventive Medicine Society organized a symposium on meningitis surveillance and immunology prevention in Hangzhou. The meeting reported the progress of prevention and control of meningitis both in the world and in China, sorted out the status quo of the current application of meningococcal vaccine (MenV) in our country, interpreted the position document of MenV vaccinated by the World Health Organization (WHO), systematically analyzed the existence of meningococcal immunization prevention in our country problem. At the meeting, at present, from the aspects of vaccine types and inoculation management, immunocompromising in the prevention of meningitis in our country faces more complicated situations and problems. The emergence of new epidemic groups, the need to expand the coverage of serogroup MenV; MenV variety, but different companies vaccination recommended different procedures, vaccination staff there is confusion; two types of vaccines and a vaccine co-exist in the vaccination management Increasing difficulty; meningococcal case monitoring report of low sensitivity. The meeting proposed to make timely adjustments to the current MenV immunization strategy in China; to formulate a unified MenV guidance on the use of vaccines, to regulate vaccination, information registration and vaccination rates; to increase the sensitivity of meningococcal monitoring and case reporting; to actively carry out MenV’s applied research .